Stragen Pharma SA, is a Swiss-based global pharma company with corporate HQs in Lyon and Geneva, specializing in specialty pharma, hard-to-make generics and consumer health, with 400+ MAs covering women’s health and critical care, since 1990. Also present across EU, UK, and UAE, Stragen is currently seeking to license/acquire MAs, new dossiers and is open to commercial/distribution partnerships.